V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006278 | 300004364 | 1.58 | 42 | Palliative (P) | 2013-08-28 | 2013-09-17 | CAPECITABINE + OXALIPLATIN | 02 | null | 300015630 | OXALIPLATIN + MDG |
| 300006279 | 300004365 | 1.74 | 66 | Curative (C) | 2015-07-10 | 2015-07-25 | FLUOROURACIL | N | Y | 300015642 | CETUXIMAB + RT |
| 300006280 | 300004367 | null | null | Adjuvant (A) | 2014-11-09 | 2014-11-09 | Gemcitabine + Capecitabine | N | N | 300015642 | CARBOPLATIN |
| 300006281 | 300004367 | null | null | null | 2013-06-19 | 2013-06-19 | CARBOPLATIN + CETUXIMAB + FU | N | Y | 300015642 | CARBOPLATIN + CETUXIMAB + FU |
| 300006282 | 300004368 | 1.69 | 87.8 | Palliative (P) | 2014-04-06 | 2014-04-25 | Imatinib 400mg | N | N | 300015693 | CAPECITABINE |
| 300006283 | 300006813 | 1.52 | 57 | Curative (C) | 2016-02-25 | 2016-03-13 | Cisplatin 7 day | N | Y | 300015697 | CARBOPLATIN + RT |
| 300006285 | 300004371 | 1.7 | 60 | Neo-adjuvant (N) | null | 2014-12-31 | CARBOPLATIN + RT | N | Y | 300015703 | CETUXIMAB + RT |
| 300006286 | 300004372 | 1.51 | 73.4 | Curative (C) | null | 2013-06-24 | Cisplatin | N | Y | 300015710 | CETUXIMAB + RT |
| 300006287 | 300004373 | 1.66 | 52 | Palliative (P) | null | 2017-08-18 | Cisplatin | N | N | 300015714 | TRIAL |
| 300006288 | 300004374 | 1.65 | 0 | Curative (C) | 2014-06-16 | 2014-06-22 | Cetuximab 7 day (>Cycle 2) | 2 | Y | 300015714 | CARBOPLATIN |
| 300006289 | 300004375 | 1.85 | 61 | Palliative (P) | 2017-03-30 | 2017-05-22 | Bevacizumab 5mg/kg | 02 | N | 300015727 | ESPAC TRIAL |
| 300006290 | 300004376 | 1.66 | 77.3 | Palliative (P) | null | 2013-03-28 | CAV | 02 | N | 300015731 | CARBOPLATIN + CETUXIMAB + FU |
| 300006291 | 300004378 | 1.64 | 47 | null | 2016-09-28 | 2018-01-23 | Capecitabine | N | N | 300015733 | CARBOPLATIN + CETUXIMAB + FU |
| 300006292 | 300004378 | 1.84 | 130.7 | Curative (C) | 2017-04-12 | 2017-04-19 | Cetuximab 7 day (>Cycle 2) | null | Y | 300015733 | CISPLATIN + FLUOROURACIL |
| 300006293 | 300004379 | 1.8 | null | Curative (C) | 2013-07-29 | 2013-08-19 | Bevacizumab 5mg/kg | N | N | 300015738 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006294 | 300004380 | 1.94 | 104.2 | Adjuvant (A) | 2014-12-27 | 2015-01-28 | CARBOPLATIN + RT | null | Y | 300015743 | CARBOPLATIN |
| 300006295 | 300004381 | 1.49 | 56.7 | Adjuvant (A) | 2013-09-01 | 2013-09-04 | Carboplatin AUC 2 - 5 | N | N | 300015744 | CAPECITABINE |
| 300006296 | 300004382 | 1.83 | 62 | Adjuvant (A) | 2016-09-07 | 2016-09-26 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300015744 | CISPLATIN + FLUOROURACIL |
| 300006297 | 300004382 | 1.64 | null | Curative (C) | 2013-10-23 | 2013-10-23 | Trial Unspecified | 02 | null | 300015744 | CAPECITABINE |
| 300006298 | 300004382 | 1.87 | 60 | Curative (C) | null | 2017-03-03 | Imatinib 400mg | N | N | 300015744 | TRIAL |
| 300006299 | 300004384 | 1.8 | 57.6 | Curative (C) | 2016-03-06 | 2016-03-21 | Carboplatin AUC 2 - 5 | Y | Y | 300015780 | CARBOPLATIN + RT |
| 300006300 | 300004385 | 1.68 | 73.3 | Curative (C) | 2016-12-11 | 2017-02-14 | ESPAC-4 TRIAL | N | null | 300015783 | CETUXIMAB + RT |
| 300006301 | 300004385 | 1.65 | 51.45 | Adjuvant (A) | 2013-08-02 | 2013-08-02 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | null | 300015783 | CARBO + FLUOROURACIL |
| 300006302 | 300004386 | 1.69 | 74.8 | Palliative (P) | null | 2015-03-24 | Capecitabine + Oxaliplatin 21day | 02 | N | 300015793 | IRINOTECAN |
| 300006303 | 300004386 | 1.51 | 72.2 | Palliative (P) | 2016-11-06 | 2016-12-02 | Cisplatin 7 day | 02 | N | 300015793 | GEMCARBO |
| 300006304 | 300004387 | 1.75 | 62.7 | Adjuvant (A) | 2015-08-03 | 2015-08-14 | CARBOPLATIN | N | null | 300015821 | HYDROXYCARBAMIDE |
| 300006305 | 300004388 | 1.69 | 65 | Palliative (P) | 2016-12-26 | 2016-12-26 | CISPLATIN + FLUOROURACIL | 02 | N | 300015834 | CARBOPLATIN |
| 300006306 | 300004390 | 1.59 | 72 | Palliative (P) | null | 2017-07-22 | NIVOLUMAB | N | N | 300015838 | OXALIPLATIN + MDG |
| 300006307 | 300004393 | 1.64 | 63.4 | Adjuvant (A) | 2016-04-12 | 2016-04-26 | Carboplatin AUC 6 - 10 | 02 | N | 300015852 | BCG |
| 300006308 | 300004395 | 1.76 | 91.4 | Adjuvant (A) | 2014-03-31 | 2014-04-16 | Cisplatin +Fluorouracil (3 wk) | 02 | N | 300015865 | CARBO + FLUOROURACIL |
| 300006309 | 300004396 | 1.7 | null | Adjuvant (A) | 2013-07-02 | 2013-07-02 | CARBOPLATIN | 2 | null | 300015867 | CARBOPLATIN |
| 300006310 | 300004396 | 1.81 | 70.3 | Palliative (P) | 2015-09-18 | 2015-09-24 | CARBOPLATIN + RT | N | N | 300015867 | CISPLATIN |
| 300006311 | 300004397 | 1.58 | null | Curative (C) | 2017-02-17 | 2017-03-18 | GemCarbo Days 1+8 | N | N | 300015870 | IRINOTECAN + MDG |
| 300006312 | 300004398 | 1.67 | 44.8 | Palliative (P) | 2017-06-18 | 2017-07-22 | Cisplatin + Etoposide po&iv 3 day | N | N | 300015872 | CARBOPLATIN + LIPOSOMAL DOX |
| 300006313 | 300004398 | null | 81.3 | Adjuvant (A) | 2014-06-27 | 2014-07-24 | ESPAC-4 TRIAL | N | null | 300015872 | CISPLATIN |
| 300006316 | 300004400 | 1.55 | 101 | null | 2017-08-19 | 2018-01-22 | Cetuximab + Radiotherapy Maint | 02 | Y | 300015891 | CAPECITABINE |
| 300006317 | 300004402 | 1.61 | 65 | Curative (C) | 2014-10-03 | 2016-05-01 | Carboplatin AUC 2 - 5 | N | Y | 300015894 | CETUXIMAB + RT |
| 300006318 | 300004402 | 1.7 | 78.4 | Curative (C) | 2014-01-16 | 2014-02-14 | Cisplatin + Fluorouracil + RT 5day | N | Y | 300015894 | CARBOPLATIN + RT |
| 300006319 | 300004403 | 1.76 | 74 | Adjuvant (A) | 2016-04-13 | 2016-04-26 | Capecitabine + Oxaliplatin 21day | 2 | N | 300015897 | CISPLATIN + FLUOROURACIL |
| 300006320 | 300004404 | 1.94 | 87.3 | Curative (C) | 2015-09-09 | 2015-09-24 | Cisplatin 7 day | N | Y | 300015907 | CISPLATIN |
| 300006321 | 300004404 | 1.6 | 0 | Curative (C) | 2014-07-30 | 2014-10-12 | Cisplatin 7 day | N | Y | 300015907 | CETUXIMAB + RT |
| 300006322 | 300004405 | 1.73 | 64.9 | Curative (C) | 2015-11-02 | 2015-11-06 | Cetuximab 7 day (>Cycle 2) | N | Y | 300015917 | CAPECITABINE + RT |
| 300006323 | 300006831 | 1.58 | null | Curative (C) | 2017-02-18 | 2017-03-03 | CISPLATIN + FLUOROURACIL | N | Y | 300015919 | CARBOPLATIN |
| 300006324 | 300004406 | 1.61 | null | Palliative (P) | 2017-05-11 | 2017-05-19 | Gemcitabine + Capecitabine | N | N | 300015921 | CISPLATIN |
| 300006325 | 300007741 | 1.65 | 65 | Curative (C) | 2016-12-11 | 2016-12-17 | Oxaliplatin + Modified de Gramont | Y | N | 300015925 | CETUXIMAB |
| 300006326 | 300004408 | null | 78.7 | Palliative (P) | 2017-02-05 | 2017-02-11 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | 300015931 | CETUXIMAB + IRINOTECAN + MDG |
| 300006327 | 300004410 | 1.65 | 88 | Disease modification (D) | 2014-09-28 | 2014-10-17 | Cisplatin +Fluorouracil (3 wk) | 2 | N | 300015936 | NOT MATCHED |
| 300006328 | 300004411 | 1.61 | 0 | null | 2013-06-08 | 2013-06-20 | Cetuximab 7 day (Cycle 1) | N | N | 300015937 | BEVACIZUMAB |
| 300006329 | 300004414 | 1.67 | 77.2 | null | null | 2015-05-21 | Cetuximab + Radiotherapy Maint | 02 | Y | 300015942 | CARBOPLATIN |
| 300006330 | 300004415 | 1.6 | 60.9 | Palliative (P) | 2017-04-10 | 2017-04-19 | CISPLATIN + FLUOROURACIL | N | N | 300015948 | TRIAL |